Search results
Our Therapeutic Areas. For more than 35 years, Gilead has discovered, developed and delivered innovative medicines in areas of great unmet medical need. Our ability to translate science into once-impossible advances has led to the commercialization of more than 29 life-changing therapies. Today, we have a robust portfolio and pipeline spanning ...
Ex-Dividend Date. Jun 14, 2024. 1y Target Est. 81.49. All. News. Press Releases. Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.
Dec 22, 2022 · Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.
The Gilead office in Miami, Fla., is home to members of the Global Patient Solutions team and employees focused on the company’s Latin America operations. Contact Information. 5200 Blue Lagoon Drive, Suite 450 Miami, FL 33126. Phone: +1 786 655 5250 +1 786 655 5250 or 800-GILEAD-5 (+1800 445 3235) 800-GILEAD-5 (+1800 445 3235)
June 20, 2024. Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention.
Jan 22, 2024 · Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer.
